Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 10:12:2977-2985.
doi: 10.2147/COPD.S148422. eCollection 2017.

Efficacy of long-term noninvasive positive pressure ventilation in stable hypercapnic COPD patients with respiratory failure: a meta-analysis of randomized controlled trials

Hao Liao #  1 , Wendi Pei #  1 , Hongfu Li #  1 , Yuwen Luo  1 , Kai Wang  1 , Rui Li  1 , Limei Xu  1 , Xin Chen  1
Affiliations
Review

Efficacy of long-term noninvasive positive pressure ventilation in stable hypercapnic COPD patients with respiratory failure: a meta-analysis of randomized controlled trials

Hao Liao et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Introduction: The efficacy of long-term noninvasive positive pressure ventilation (NPPV) in stable hypercapnic COPD patients with respiratory failure remains unclear. The aim of this meta-analysis was to critically assess the efficacy of long-term NPPV on mortality, acute exacerbation, exercise capacity, symptoms and significant physiological parameters (lung function, respiratory muscle function and gas exchange).

Patients and methods: We performed an electronic literature search using the PubMed, Cochrane Library, Embase, OVID and Chinese Biomedical Literature Database in May 2017. Studies comparing treatment effects of NPPV with oxygen therapy in stable hypercapnic COPD patients with respiratory failure were conducted, and at least one of the following parameters were reviewed: frequency of acute exacerbation, mortality, lung function, respiratory muscle function, gas exchange, exercise capacity.

Results: Seven studies with 810 subjects were identified. The partial pressure of arterial carbon dioxide (PaCO2) significantly decreased in patients who received long-term NPPV (weighted mean difference [WMD] -3.73, 95% CI: -5.83 to -1.64, P=0.0005). No significant difference was found in mortality, partial pressure of arterial oxygen (PaO2), frequency of acute exacerbation, lung function, respiratory muscle function and exercise capacity. The subgroup analysis showed that NPPV significantly improved the survival of patients when it was targeted at greatly reducing hypercapnia (WMD 0.35, 95% CI: 0.19 to 0.64, P=0.0006).

Conclusion: The results indicate that long-term NPPV decreases the PaCO2 of stable hypercapnic COPD patients with respiratory failure and improves mortality with the aim of reducing PaCO2.

Keywords: COPD; gas change; meta-analysis; mortality; noninvasive positive pressure ventilation.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flowchart of the study selection process. Abbreviation: NPPV, noninvasive positive pressure ventilation.
Figure 2
Figure 2
Risk of bia summary. Notes: The reviewers made judgments about the risk of bias for each item in each included study. +, low summary risk; ?, unclear risk.
Figure 3
Figure 3
Mortality forest plot. Notes: Experimental, treatment group; control, control group. Abbreviations: M–H, Mantel–Haenszel method; CI, confidence interval.
Figure 4
Figure 4
Partial pressure of carbon dioxide in arterial blood forest plot. Notes: Experimental, treatment group; control, control group. Abbreviation: CI, confidence interval.
Figure 5
Figure 5
Partial pressure of oxygen in arterial blood forest plot. Notes: Experimental, treatment group; control, control group. Abbreviation: CI, confidence interval.
See this image and copyright information in PMC

References

    1. Ojo O, Lagan AL, Rajendran V, et al. Pathological changes in the COPD lung mesenchyme – novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther. 2014;29(2):121–128. - PubMed
    1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. - PMC - PubMed
    1. Tan WC, Mahayiddin AA, Charoenratanakul S, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (UPDATE 2014) Global Initiative for Chronic Obstructive Lung Disease 2014 GOLD. Respirology. 2005;10(1):9–17. - PMC - PubMed
    1. Slenter RH, Sprooten RT, Kotz D, Wesseling G, Wouters EF, Rohde GG. Predictors of 1-year mortality at hospital admission for acute exacer-bations of chronic obstructive pulmonary disease. Respiration. 2013;85(1):15–26. - PubMed
    1. McEvoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009;64(7):561–566. - PubMed

MeSH terms